Prospective Study to Determine the Effect of Subconjunctival Bevacizumab (AVASTIN) in Corneal Neovascularization

NCT00555594 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Corneal Neovascularization

Interventions

DRUG: Bevacizumab (Avastin)

Sponsor

Asociación para Evitar la Ceguera en México

Collaborators

[object Object]
[object Object]